bestbion dx - Diagnostische Produkte und Beratung GmbH has been a 100% direct subsidiary of SD Biosensor Inc. since fiscal year 2022 and conducts direct sales and service for in-vitro diagnostics (IVD). The company's product portfolio comprises analytical devices, reagents and consumables as well as related services, serving research in biochemistry, biotechnology, the pharmaceutical industry, quality assurance, laboratory diagnostics and healthcare. In manufacturer cooperation the company relies on exclusive marketing and distribution rights for Germany, Austria and Switzerland and advances projects for laboratory automation and the market launch of point-of-care PCR (including the "Standard M" product line). The quality management system is certified according to EN ISO 9001:2015 and the average number of employees during the fiscal year was 42 (exclusively salaried staff). The company is a small company under § 267 (1) HGB and is therefore not required to publish a profit-and-loss statement.
der Vertrieb von diagnostischen Produkten und die Beratung in diesen Bereichen.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Köln Local Court, HRB 73687 (as of 1 November 2026)
| Name | Type | City |
|---|---|---|
| Sascha Przybilla | Geschäftsführer(in) | Neckoiartenzlingen |
| Changmin Sung | Geschäftsführer(in) | Köln |
Source: German Commercial Register (Handelsregister) Köln Local Court, HRB 73687 (as of 1 November 2026)
| Date | Event Type | Event |
|---|---|---|
| 12.05.2023 | Business Address Change | An der Hasenkaule 10, Halle 9, 50354 Hürth |
| 14.01.2014 | Business Address Change | Horbeller Straße 33, 50858 Köln |
| 14.01.2014 | Gesellschaftsvertrag amended | Gesellschaftsvertrag |
| Date | Type | Change | Total Capital |
|---|---|---|---|
| 12.10.2011 | Share Capital Set | — | 25.000 € |
Source: German Commercial Register (Handelsregister) Köln Local Court, HRB 73687 (as of 1 November 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2024 | small company1 | -€1,228,679 | €6,040,598 | 34 |
| 2023 | Rohergebnis€4.1M2 | -€1,794,999 | €6,331,134 | 42 |
| 2022 | Rohergebnis€8.5M2 | €2,170,945 | €10,173,310 | 35 |
| 2021 | Rohergebnis€11.1M2 | €4,338,520 | €7,528,677 | 32 |
| 2020 | small company1 | — | €5,898,688 | 23 |
| 2019 | small company1 | €75,048 | €1,228,448 | 20 |
| 2018 | small company1 | €68,655 | €1,034,758 | 19 |
| 2017 | small company1 | -€94,710 | €917,974 | 21 |
| 2016 | small company1 | €23,667 | €796,673 | 22 |
| 2015 | small company1 | €172,731 | €776,200 | — |
1 Small companies are not required to publish a profit-and-loss statement (§ 326 (1) HGB). The figure shown is the statutory ceiling under § 267 HGB where the balance-sheet total makes it binding — a company may exceed at most one of the three size criteria.
2 Rohergebnis nach § 276 HGB: Umsatzerlöse abzüglich Materialaufwand bzw. Herstellungskosten. Kleine und mittelgroße Kapitalgesellschaften dürfen diese Posten zusammenfassen; die Umsatzerlöse selbst sind dann nicht veröffentlicht und liegen über dem Rohergebnis.
Sign in to download data
Source: German Commercial Register (Handelsregister) Köln Local Court, HRB 73687 (as of 1 November 2026)
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €2,974,830 | 84.7% |
| Depreciation | €530,238 | 15.1% |
| Interest & Similar | €8,433 | 0.2% |
